Murcia atrial fibrillation project II: protocol for a prospective observational study in patients with atrial fibrillation
Introduction Atrial fibrillation (AF) is characterised by a high stroke risk. Vitamin K antagonists (VKAs) are the most commonly used oral anticoagulants (OACs) in Spain, but their efficacy and safety depend on the time in therapeutic range of International Normalized Ratio (INR) 2.0–3.0 over 65%–70...
Saved in:
| Main Authors: | José Miguel Rivera-Caravaca, Francisco Marín, María Asunción Esteve-Pastor, Josefa Gálvez, Gregory Y.H. Lip, Vicente Vicente, Vanessa Roldán |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2019-12-01
|
| Series: | BMJ Open |
| Online Access: | https://bmjopen.bmj.com/content/9/12/e033712.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Remnant–to–LDL cholesterol discordance as a predictor of thromboembolic events in anticoagulated patients with atrial fibrillation: a report from the prospective Murcia AF project III (MAFP-III) cohort study
by: Eva Soler-Espejo, et al.
Published: (2025-07-01) -
The triglyceride-glucose index, a marker of insulin resistance, as a predictor of thrombotic risk in atrial fibrillation
by: José Miguel Rivera-Caravaca, et al.
Published: (2025-07-01) -
Multimorbidity and atrial fibrillation: Envisioning integrated approaches to complex health needs
by: Giulio Francesco Romiti, et al.
Published: (2025-08-01) -
Nonpharmacological Therapies for Atrial Fibrillation
by: Jane C. Caldwell, et al.
Published: (2011-01-01) -
HYPERTHYROIDISM AND ATRIAL FIBRILLATION
by: I. M. Marusenko, et al.
Published: (2017-07-01)